MSc. Martina Wirtz

Scientific co-worker

Martina Wirtz studied chemistry at the Technichal University of Munich. For her bachelor thesis she optimised the regeneration conditions of a reusable microarray-chip for the detection of ochratoxin A, aflatoxin B1 and aflatoxin B2. This was followed by her master studies at the TU Munich. Her master thesis was concerned with the development of "New choline-based radiopharmaceuticals for the functional imaging of oncological diseases". These investigations are now continued in the frame of her dotoral work.


[Translate to en:]

  • Martina Weineisen, Jakub Simecek, Margret Schottelius, Markus Schwaiger, Hans-Jürgen Wester, Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer. EJNMMI Research 2014, 4:63.
  • Baranyai Z, Reich D, Vagner A, Weineisen M, Toth I, Wester, HJ, Notni J. A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform. Dalton Transactions 2015, 44 (24), 11137-11146
  • Herrmann K, Bluemel C, Weineisen M, Schottelius M, Wester HJ, Czernin J, Eberlein U, Beykan S, Lapa C, Riedmiller H, Krebs M, Kropf S, Schirbel A, Buck AK, Lassmann M. Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy. J Nucl Med. 2015, 56 (6), 855-861  
  • Weineisen M, Robu S, Schottelius M, Wester HJ. Neue und bewährte Radiopharmaka für die Diagnostik und Therapie des Prostatakarzinoms. Nuklearmediziner. 2015;38:89-98
  • Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, Kubler H, Thalgott M, Navab N, Schwaiger M, Wester HJ, Gschwend JE, Eiber M. Prostate-specific Membrane Antigen-radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer. Eur Urol 2015
  • Weineisen M, Schottelius M, Simecek S, Baum RP, Yildiz A, Beykan S, Kulkarni HR, Lassmann M, Klette I, Eiber M, Schwaiger M, Wester HJ. 68Ga- and 177Lu-labeled PSMA I&T: Optimization of a PSMA targeted theranostic concept and first proof of concept human studies. J Nucl Med. 2015